Accumetra

Accumetra develops cloud-based software systems and calibration solutions for CT lung cancer screening programs. The company offers two primary product lines: ScreeningPLUS, a comprehensive CT lung cancer screening management system that integrates best practices from the I-ELCAP lung cancer screening initiative, featuring web-based forms, automated reporting, and EHR electronic communication capabilities; and the ACQA (Accumetra Quality Assurance) system, which provides CT scanner calibration phantoms (CTLX1 and CTLX2) and automated cloud-based phantom analysis services for ensuring consistent lung nodule volume measurement performance according to RSNA/QIBA guidelines. The ACQA system delivers analysis within 10 minutes, covers nodules up to 200 mm, and uses phantoms that scan in under 5 minutes with ultra-low cost compared to competitive offerings. Accumetra has published peer-reviewed research on CT image calibration, lung nodule measurement bias and precision prediction, and AI-compatible quantitative imaging approaches. The company collaborates with major imaging vendors including GE Healthcare and maintains an active network of contributing clinical sites to support global CT image quality standards. Products are designed for hospital radiology departments and clinical screening centers performing low-dose CT lung cancer screening.